Live Breaking News & Updates on Solid biosciences

Stay informed with the latest breaking news from Solid biosciences on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Solid biosciences and stay connected to the pulse of your community

Solid Biosciences Inc. (NASDAQ:SLDB) Short Interest Up 21.8% in December

Solid Biosciences Inc. (NASDAQ:SLDB) Short Interest Up 21.8% in December
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

United-states , Alexander-cumbo , Vanguard-group-inc , Securities-exchange-commission , Great-point-partners , Nasdaq , Millennium-management , Solid-biosciences-inc , Perceptive-advisors-llc , Alyeska-investment-group , Renaissance-technologies , Cantor-fitzgerald

Insider Selling: Solid Biosciences Inc. (NASDAQ:SLDB) CFO Sells 3,935 Shares of Stock

Solid Biosciences Inc. (NASDAQ:SLDB – Get Free Report) CFO Kevin Tan sold 3,935 shares of the company’s stock in a transaction on Tuesday, January 9th. The stock was sold at an average price of $8.20, for a total value of $32,267.00. Following the sale, the chief financial officer now directly owns 9,308 shares in the […]

United-states , Kevin-tan , Charles-schwab-investment-management-inc , Prudential-financial-inc , Nasdaq , Solid-biosciences-inc , Geode-capital-management , Asset-management-inc , Securities-exchange-commission , Cantor-fitzgerald , Atria-wealth-solutions-inc , Solid-biosciences-company-profile

Solid Biosciences Inc. announced that it expects to receive $108.858551 million in funding from a group of investors

Solid Biosciences Inc. entered into a securities purchase agreement with certain institutional accredited investors to issue common stock and Pre-Funded warrants for a aggregate proceeds of...

Perceptive-advisors , Solid-biosciences-inc , Bain-capital-life-sciences , Deerfield-management-company , Solid-biosciences , Adage-capital-partners , Janus-henderson-investors , Vestal-point-capital , Bain-capital-private-equity , Private-placement , Securities-purchase

DelveInsight Business Research, LLP: In-Depth Market Analysis of Rare Genetic Disorders: Familial Chylomicronemia Syndrome (FCS), Netherton Syndrome, and Acromegaly

DelveInsight Business Research, LLP: In-Depth Market Analysis of Rare Genetic Disorders: Familial Chylomicronemia Syndrome (FCS), Netherton Syndrome, and Acromegaly
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Japan , United-states , Avanti-biosciences , Daiichi-sankyo , Stefan-klotter , Aelis-farma , Vyant-bio , Sixera-pharma , Reveragen-biopharma , Annovis-bio , Shruti-thakur , Linearis-circumflexa

In-Depth Market Analysis of Rare Genetic Disorders: Familial Chylomicronemia Syndrome (FCS), Netherton Syndrome, and Acromegaly

/PRNewswire/ -- Significant breakthroughs in the rapid and cost-effective analysis of the human genome have brought clarity to the path of discovering the...

Japan , United-states , Linearis-circumflexa , Vyant-bio , Aelis-farma , Daiichi-sankyo , Sixera-pharma , Shruti-thakur , Annovis-bio , Avanti-biosciences , Reveragen-biopharma , Pfizer

Insider Selling: Solid Biosciences Inc. (NASDAQ:SLDB) COO Sells $14,920.26 in Stock

Solid Biosciences Inc. (NASDAQ:SLDB – Get Free Report) COO David T. Howton sold 5,367 shares of Solid Biosciences stock in a transaction on Monday, December 4th. The stock was sold at an average price of $2.78, for a total value of $14,920.26. Following the sale, the chief operating officer now owns 7,684 shares in the […]

United-states , Davidt-howton , Charles-schwab-investment-management-inc , Solid-biosciences-inc , Atria-wealth-solutions-inc , Prudential-financial-inc , Cantor-fitzgerald , Asset-management-inc , Nasdaq , Mirabella-financial-services , Solid-biosciences

Jessie Hanrahan Sells 4,879 Shares of Solid Biosciences Inc. (NASDAQ:SLDB) Stock

Solid Biosciences Inc. (NASDAQ:SLDB – Get Free Report) insider Jessie Hanrahan sold 4,879 shares of Solid Biosciences stock in a transaction that occurred on Monday, December 4th. The stock was sold at an average price of $2.78, for a total value of $13,563.62. Following the transaction, the insider now owns 6,983 shares of the company’s […]

United-states , Jessie-hanrahan , Asset-management-inc , Solid-biosciences-inc , Solid-biosciences-company-profile , Atria-wealth-solutions-inc , Prudential-financial-inc , Charles-schwab-investment-management-inc , Mirabella-financial-services , Nasdaq , Cantor-fitzgerald , Solid-biosciences

Solid Biosciences Shares Jump After FDA Fast-Tracks SGT-0003

By Dean Seal

Shares of Solid Biosciences rose after the company said regulators have granted their fast-track designation to its treatment for Duchenne muscular dystrophy.

The stock was up...

Drug-administration , Dean-seal , Solid-biosciences , Dow-jones , Markets ,

Solid Biosciences Says FDA Grants Fast Track Designation For Gene Therapy Candidate SGT-003

Life sciences company Solid Biosciences Inc. (SLDB) announced Thursday that it has received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for SGT-003, the company's next-generation Duchenne muscular dystrophy gene therapy candidate.

Drug-administration , Solid-biosciences-inc , Solid-biosciences , Fast-track-designation , Fda , S-food-and-drug-administration- , Uchenne-muscular-dystrophy- , Olid-biosciences , Ldb , Ife-sciences-company-solid-biosciences- , Gt-003

Solid Biosciences Says FDA Grants Fast Track Designation to Duchenne Muscular Dystrophy Gene Therapy; Shares Rise

-- Solid Biosciences said Thursday that the US Food and Drug Administration has granted fast track designation to SGT-003, the company's Duchenne muscular dystrophy gene therapy candidate.
The...

Solid-biosciences-inc , Solid-biosciences , Markets ,